Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult

MEDICINES DISCOVERY CATAPULT LIMITED · Contract details notice on Find a Tender

Tender information last checkedLast checked 5 Oct 2026, 09:08.

Opportunity overview

Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics. The purchase of the equipment will be at a value of £220,000, with the possibility for four twelve month extension of warranty periods.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Contract value
£344k
Awarded
Not supplied
Contract signed
18 Dec 2025
Including VAT
£412.8k
Award ID
1
Status
active
Identifier
GB-PPON PBMJ-4568-WMPX
Location
Pleasanton, US, CA 94588-3260, United States

Classification

No classification was supplied.

Lots

  • Lot 1Value not stated

Documents and notices

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-05f0dd
Status
complete
Procurement Method
direct
Procurement Method Details
Direct award
Why this procedure was chosen
Single supplier - technical reasons Medicines Discovery Catapult (MDC) intends to award a contract for the purchase of a Xenium single-cell spatial transcriptomics/proteomics instrument to 10X Genomics, on the basis that no reasonable alternative or substitute exists which meets the specific technical and operational requirements of the organisation. Independent comparative studies have demonstrated that alternative platforms currently on the market exhibit significantly higher levels of background noise, reducing data quality in single cell spatial analysis. MDC has verified these performance results and determined that the Xenium system is uniquely capable of delivering the sensitivity and precision required for our research and service activities. Beyond this the Xenium platform also offers operational advantages. It enables the use of panels with a low minimum run size, which aligns closely with the typical experimental scale within MDC. Competing systems require substantially higher minimum slide numbers, making them unsuitable and leading to inefficient use of resources. In addition, acquiring the Xenium system will strengthen MDC's national role by providing UK drug discovery organisations access to a capability that is not currently available within any UK based CRO. This avoids duplication with existing commercial provider and ensures MDC can offer new and complementary capabilities to the wider life sciences community.

Legal basis

Id
2023/54
Scheme
UKPGA

Procedure reasons

Entry 1
Id
singleSuppliersTechnicalReasons

Lots and requirements

Entry 1
Id
1
Status
complete

Published documents

Entry 1
Id
conflictOfInterest
Document Type
conflictOfInterest
Description
Not published

Buyer, suppliers and contacts

Organisation 1
Name
MEDICINES DISCOVERY CATAPULT LIMITED
Id
GB-COH-09928547

Identifier

Scheme
GB-COH
Id
09928547

Additional Identifiers

Entry 1
Scheme
GB-PPON
Id
PJPQ-6911-DQYY

Address

Street Address
Block 35g, Mereside Alderley Park
Locality
Macclesfield
Postal Code
SK10 4ZF
Country
GB
Country Name
United Kingdom
Region
UKD62

Contact

Roles

buyer

Details

Classifications

Entry 1
Scheme
UK_CA_TYPE
Id
publicAuthoritySubCentralGovernment
Description
Public authority - sub-central government
Organisation 2
Name
10x Genomics Inc
Id
GB-PPON-PBMJ-4568-WMPX

Identifier

Scheme
GB-PPON
Id
PBMJ-4568-WMPX

Address

Street Address
6230 Stoneridge Mall Road
Locality
Pleasanton
Postal Code
CA 94588-3260
Country
US
Country Name
United States
Region
US

Contact

Roles

supplier

Details

Scale
sme
Vcse
No
Public Service Mission Organization
No
Sheltered Workshop
No

Award information

Award 1
Id
1
Status
active
Main Procurement Category
goods

Items

Item 1
Id
1
Related Lot
1

Additional Classifications

Entry 1
Scheme
CPV
Id
38000000
Description
Laboratory, optical and precision equipments (excl. glasses)

Delivery locations

Entry 1
Region
UK
Country
GB
Country Name
United Kingdom

Suppliers

Supplier 1
Id
GB-PPON-PBMJ-4568-WMPX
Name
10x Genomics Inc

Related lots

1

Contracts and changes

Entry 1
Id
1
Award ID
1
Title
Xenium Single-cell Spatial Transcriptomics/Proteomics Instrument for Medicines Discovery Catapult
Status
active
Has Renewal
Yes
Above Threshold
Yes
Date Signed
18 Dec 2025, 00:00
No Agreed Metrics Rationale
not applicable

Period

Starts
18 Dec 2025, 00:00
Ends
17 Dec 2026, 23:59
Max Extent Date
17 Dec 2030, 23:59

Renewal

Description
Maintenance

Value

Including VAT
412,800
Amount
344,000
Currency
GBP

Documents

Entry 1
Id
000331-2026
Document Type
contractNotice
Notice Type
UK7
Description
Contract details notice on Find a Tender
Published
5 Jan 2026, 14:03
Format
text/html

Recorded locations

  • Buyer location · Macclesfield · UKD62 · SK10 4ZF · United Kingdom

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. 000331-2026Contract details notice on Find a Tender ·